Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial (2022)
Attributed to:
Evaluating new healthcare technologies in cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.pmed.1003998
PubMed Identifier: 35671327
Publication URI: http://europepmc.org/abstract/MED/35671327
Type: Journal Article/Review
Parent Publication: PLOS Medicine
Issue: 6
ISSN: 1549-1277